Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Longitudinal Research02:20

Longitudinal Research

13.7K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.7K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

911
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
911
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

5.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.2K
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

257
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
257
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

132
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
132
Stimulants01:29

Stimulants

1.4K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using State Administrative Data to Examine Aspects of Autistic Adult Life: A Comparative Analysis of Identification, Voting, Marriage, and Parenting.

Autism in adulthood·2026
Same author

Fast Estimation and Valid Statistical Inference for Mixed-Effect Location-Scale Models Using Variational Inference.

Statistics in medicine·2026
Same author

m-DASC: Measuring Subjective Effects of Very Low Doses of Psychedelic Drugs.

Psychedelic medicine (New Rochelle, N.Y.)·2026
Same author

Association of short-term ambient environmental exposures with suicide and drug overdose deaths among U.S. veterans.

American journal of epidemiology·2026
Same author

Modeling intraindividual means and variances from ecological momentary assessment data: comparing standard computational formulas to mixed-effects location-scale model estimates.

Journal of behavioral medicine·2026
Same author

Clinical and Genetic Evaluation of Suicide Death with and without Interpersonal Trauma Exposure.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Apr 16, 2026

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
09:50

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

11.7K

CYP2A6 Longitudinal Effects in Young Smokers.

Dale S Cannon1, Tait R Medina2, Robin J Mermelstein3

  • 1Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT; dale.cannon@hsc.utah.edu.

Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|March 7, 2015
PubMed
Summary

CYP2A6 genotype influences smoking habits over time. While slow metabolism is protective initially, normal metabolism becomes a risk factor for smoking frequency and nicotine dependence by young adulthood.

More Related Videos

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

8.0K
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

13.8K

Related Experiment Videos

Last Updated: Apr 16, 2026

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
09:50

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

11.7K
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

8.0K
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

13.8K

Area of Science:

  • Pharmacogenetics
  • Addiction Science
  • Behavioral Genetics

Background:

  • The CYP2A6 gene plays a crucial role in nicotine metabolism.
  • Understanding genotype-specific effects on smoking is vital for targeted interventions.
  • Novice smokers exhibit unique responses to nicotine metabolism variations.

Purpose of the Study:

  • To investigate the longitudinal effects of CYP2A6 genotypes on smoking frequency and nicotine dependence in young smokers.
  • To analyze how predicted nicotine metabolic rate (CDPR) categories influence smoking behaviors over time.
  • To identify time-dependent shifts in genotype-related risks for smoking.

Main Methods:

  • Utilized growth-curve models with longitudinal data from 296 young smokers (ages 16-22).
  • Categorized CYP2A6 diplotypes into Normal, Intermediate, and Slow predicted metabolic rates (CDPR).
  • Assessed smoking frequency (days smoked) and nicotine dependence (youth NDSS) over six years.

Main Results:

  • Initially, Intermediate CDPR was a risk for smoking and dependence, while Slow CDPR predicted discontinuation.
  • Over time, these effects reversed, with Normal CDPR becoming the primary risk factor by young adulthood.
  • Significant time-by-CDPR interactions altered the risk profiles of different metabolic rates.

Conclusions:

  • CYP2A6 genotypes have dynamic risk and protective effects on smoking initiation and progression.
  • Normal nicotine metabolism, initially considered neutral, emerges as a significant risk factor for continued smoking in young adults.
  • These findings highlight the importance of considering developmental trajectories in pharmacogenetic research on smoking cessation.